Kevin Xiong

Kevin Xiong is a Senior Research Associate Scientist at Stablix, Inc., with extensive experience in biomedical research and technology. At CAMP4 Therapeutics, Kevin advanced CRISPRa/i and scRNA-seq technologies to explore enhancer/gene pairs and their transcriptional interactions. Previously, Kevin played a vital role in NGS analyses at Brigham and Women's Hospital, focusing on the mechanisms of transcription in therapeutic leads. Kevin's research on pulmonary fibrosis and cell therapy contributed significantly to the understanding of Mesenchymal Stromal Cells and signaling pathways. Earlier experiences include research at the National Institute of Environmental Health Sciences and tutoring in mathematics at Kumon North America. Kevin holds a Bachelor of Science in Bioengineering and Biomedical Engineering from the University of Maryland.